Literature DB >> 29666081

Mantle cell lymphoma presenting as bilateral adrenal huge masses.

Abtin Doroudinia1, Mehrdad Bakhshayesh Karam2, Mostafa Ranjbar1, Arash Nikmanesh3, Payam Mehrian4.   

Abstract

We present a middle-aged woman complaining of weakness, lethargy and weight loss for 6 months. Positron emission tomography (PET)/CT scan revealed huge bilateral adrenal masses with intense 18F-fluorodeoxyglucose avidity. Biopsy and immunohistochemical staining were compatible with mantle cell lymphoma (MCL). The patient received six cycles of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) followed by four cycles of intrathechal methotrexate chemotherapy. Bone marrow aspiration biopsy was performed for initial staging and also before bone marrow transplantation. Follow-up PET/CT scan after completion of chemotherapy and before bone marrow transplantation demonstrated complete metabolic response with no evidence of abnormal metabolic activity in either adrenal gland or bone marrow. MCL has an aggressive nature and is usually considered incurable; however, there have been a few reports indicating favourable treatment response when MCL is rarely arising from the adrenal glands. Dramatic response of a primary adrenal MCL to R-CHOP is documented in this case. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  chemotherapy; oncology; radiology

Mesh:

Substances:

Year:  2018        PMID: 29666081      PMCID: PMC5905789          DOI: 10.1136/bcr-2017-223247

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  SOX11 is a mantle cell lymphoma oncogene.

Authors:  Adolfo A Ferrando
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

Review 2.  Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

Authors:  Martin Dreyling; Igor Aurer; Sergio Cortelazzo; Olivier Hermine; Georg Hess; Mats Jerkeman; Steven Le Gouill; Vincent Ribrag; Marek Trněný; Carlo Visco; Jan Walewski; Francesco Zaja; Pier Luigi Zinzani
Journal:  Leuk Lymphoma       Date:  2017-11-27

3.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 5.  Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.

Authors:  Birgitta Sander
Journal:  Semin Diagn Pathol       Date:  2011-08       Impact factor: 3.464

6.  Primary Non Hodgkin's Lymphoma of Left Adrenal Gland - A Rare Presentation.

Authors:  Anil Khurana; Paramjeet Kaur; Ashok K Chauhan; Sant Parkash Kataria; Nupur Bansal
Journal:  J Clin Diagn Res       Date:  2015-04-01

7.  Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.

Authors:  Olaf Determann; Eva Hoster; German Ott; Heinz Wolfram Bernd; Christoph Loddenkemper; Martin Leo Hansmann; Thomas E F Barth; Michael Unterhalt; Wolfgang Hiddemann; Martin Dreyling; Wolfram Klapper
Journal:  Blood       Date:  2007-12-12       Impact factor: 22.113

Review 8.  Advances in the understanding of mantle cell lymphoma.

Authors:  Pedro Jares; Elías Campo
Journal:  Br J Haematol       Date:  2008-04-10       Impact factor: 6.998

Review 9.  Primary adrenal lymphoma.

Authors:  Andrew P Grigg; Joseph M Connors
Journal:  Clin Lymphoma       Date:  2003-12

10.  Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis.

Authors:  Ana Mozos; Hongtao Ye; Wen-Yu Chuang; Jan-Show Chu; Wan-Ting Huang; Han-Ku Chen; Yung-Hsiang Hsu; Chris M Bacon; Ming-Qing Du; Elias Campo; Shih-Sung Chuang
Journal:  Mod Pathol       Date:  2009-06-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.